I am thrilled to announce that global health expert Aurélia Nguyen will be joining CEPI as our new Deputy CEO on October 1. Aurélia comes from Gavi, the Vaccine Alliance and brings a wealth of experience from both the multilateral and private sectors to what is going to be a critical role.

📣We are delighted to announce that Brazil’s Bio-Manguinhos/Fiocruz has joined CEPI’s network of vaccine manufacturers in the Global South, working to support faster and more equitable responses to future emerging infectious disease threats. cepi.net/mobilising-bra…

That’s a wrap on the Global Pandemic Preparedness Summit 2024 👏 The two-day summit, co-hosted by Ministério da Saúde 🩵, Fiocruz, and CEPI featured more than 20 sessions and 80 speakers, advancing critical conversations that will help better prepare the world for future pandemic threats.

.CEPI & WHO call for an expansion of pandemic research 🔬: focus on families of pathogens in addition to individual disease threats. This approach boosts readiness for unforeseen outbreaks, zoonotic spill-overs, and the hypothetical threat of a ‘pathogen X’:

📢 The Global Pandemic Preparedness Summit 2024: Outcomes Report is now available—featuring key outcomes, reflections, and recommendations to emerge from #GPPS2024. Read the full report: bit.ly/3XOwLED

Delighted to sign an agreement with CEPI. CEPI and PAHO will work together to advance regulatory harmonization and response to health emergencies in the Americas. ℹ️ paho.org/en/news/23-9-2…

📣CEPI has today launched a new Biosecurity Strategy aimed at bolstering global health security and underscoring its commitment to tackling emerging epidemic threats🌍 ➡️bit.ly/4doCup0

A huge congratulations to David Baker—University of Washington—who today shares the The Nobel Prize in Chemistry for his contributions to computational protein design, along with Google DeepMind's Demis Hassabis and John M. Jumper for their work on the prediction of protein structures

Over 8 million people. That is the number of people who might be alive today if the international community had accomplished the 100 Days Mission to develop safe and effective new vaccines against SARS-CoV-2 in three months. 👉 cepi.net/100-days-save-… Imperial College London

Switzerland renews its commitment to CEPI! 🇨🇭 “We are honoured that the Government of Switzerland has renewed its commitment to CEPI with a pledge of CHF 10 million covering its participation for the next three years,” CEPI’s CEO Dr Richard Hatchett said during his meeting with

This is an historic step forward in tackling one of the most pressing challenges of our time – a challenge that can only be overcome effectively through international cooperation. CEPI commends the commitment of countries and negotiators to advancing this once-in-a-generation

🗞️ Our June newsletter is out! We spotlight a new project to develop an all-in-one vaccine for deadly filoviruses like Marburg & Ebola, recap CEPI at the G20 Health Working Group, and new Innovations for Impact stories on speed & access. Read more ⬇️ bit.ly/4lptV1M

"Speeding up vaccine development to 100 days could better prepare the world for the next outbreak" writes our CEO Richard Hatchett in today’s print copy of The Guardian as part of the #GlobalHealthResilience campaign. globalcause.co.uk/global-resilie…

Honored to share that Germany has renewed its longstanding commitment to and partnership with CEPI, with a new EUR 100 million pledge to support our critical work over the next five years. Germany’s renewed commitment to CEPI reflects true global leadership at a time when its

"Pandemics are not hypothetical risks. They are existential threats and defending against them is both a strategic and moral imperative.” That was the clear message from Dorothee Bär, German Federal Minister of BMFTR & CEPI CEO Richard Hatchett below ⬇️bit.ly/46ZzwWY